On Tuesday, Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), lost -5.37% to $0.0740. 34.24 million shares of the company were exchanged.
Aeterna Zentaris Inc. (AEZS) (AEZ.TO) declared that the independent Data and Safety Monitoring Board has recommended that the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer, continue as planned. The DSMB’s decision follows completion of its pre‑specified second interim analysis on efficacy and safety for the ZoptEC Phase 3 trial at about 192 events. In April 2015 , the DSMB made the same recommendation following its first pre-specified analysis on safety and futility at about 124 events. A final analysis of the data is predictable at about 384 events.
David Dodd , Chairman and CEO of Aeterna Zentaris, commented, “This positive second recommendation from the DSMB is an important milestone since it supports our continuation of the ZoptEC Phase 3 trial in endometrial cancer until its completion. The DSMB recommendation was based upon a comprehensive review of the data on efficacy and safety. We believe that zoptarelin doxorubicin has the potential to become the first FDA approved medical therapy for advanced, recurrent endometrial cancer. This could result in its rapid adoption as a novel core therapy for patient treatment and administration, and therefore, would represent a noteworthymarket opportunity for the Company. Moving forward, we are ongoing to develop our commercialization plans regarding zoptarelin doxorubicin in this indication, counting establishing additional partnerships in territories that won’t be pursued by Aeterna Zentaris. In addition, contingent on the success of the ZoptEC program, we have additional areas of interest for further therapeutic development, counting ovarian, prostate and triple negative breast cancer.”
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health.
Shares of Visa Inc (NYSE:V), surged 0.01% to $75.00, during its last trading session.
Visa Inc. (NYSE:V) and FireEye, Inc. (FEYE) declared the launch of Visa Threat Intelligence, Powered by FireEye. Tailored to the needs of the payments industry, this new service will deliver real-time threat information to merchants and issuers so they can quickly assess and act on the most critical cyber-attacks that could breach their payment systems.
Visa Threat Intelligence is the first product accessible as part of a new global planned partnership between Visa Inc. and FireEye. Starting late 2015, subscribers will gain access to a powerful web portal that distills the latest proprietary cyber intelligence relevant to payment systems into actionable information, counting timely alerts on malicious actors, methods, trends in cyber-attacks, and in-depth forensic analysis from recent data breaches.
In addition, Visa Threat Intelligence will provide a secure platform where clients can opt to form trusted communities and safely exchange real-time threat intelligence. Leveraging community-based intelligence is crucial to a comprehensive defense strategy because many attack groups run campaigns that target organizations with a similar profile.
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Finally, Shares of Applied Materials, Inc. (NASDAQ:AMAT), ended its last trade with -2.95% loss, and closed at $15.14.
Applied Materials, Inc. unveiled two new systems that enable the volume production of high-resolution, thin and lightweight flexible OLED displays for mobile products and TVs. The Applied AKT-20K(TM) TFE PECVD and Applied AKT-40K(TM) TFE PECVD tools deliver breakthroughs in materials engineering to deposit thin-film encapsulation barrier layers that are crucial for protecting extremely sensitive OLED devices. These systems allow display makers to replace the rigid insulating front glass on the devices and bring to market bendable and curved displays for a new generation of consumer products.
The vibrant color and low power consumption of OLED displays have driven their rapid adoption in smartphones, with flexible OLED now the fastest growing display segment in the mobile industry. The new TFE systems (20K for 925 x 1500mm and 40K for 1250 x 2200mm) address different display market segments to meet the growing demand for more versatile, thinner and lighter small- and large-area flexible OLEDs.
Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, flat panel display, solar photovoltaic (PV), and related industries worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
